Gene Therapy for Rare Disorders 2020 | Booth and Presentation

As of 11 March 2020- This event is being postponed until early 2020 due to Covid-19 Pandemic

Attend our talk presented by Rachel Smith, Project Director, Veristat LLC

Presentation Title: Gene Therapy: How we changed the Paradigm |Case studies from Advanced therapy Trials

Learning Points:

Building a road map to market for the first approved gene therapy
Collaborating with global regulatory agencies to ensure full buy-in on pathways for regulatory approval
Understanding products that are varied, complex and require bespoke strategies for manufacturing, distribution, and administration
Utilizing Long-Term Follow-Up studies to support safety and efficacy data during and beyond approval

Meet Veristat at Gene Therapy for Rare Disorders, 30 March to 2 April 2020

Whether you have a compound and need to get started on your IND, or want to recruit patients quickly to get your early phase trials running or just need medical writing or biostatistical support for your programs - Veristat can help. We provide impactful solutions on both a full-service or functional service basis.

Schedule A Meeting

Schedule a meeting by filling out the form on the right. Find out how we can help you advance your next clinical trial or regulatory submission to successful outcomes. Or learn more about our capabilities.